Showing results (31-40 of 163) with videos related to
Sort By:
Pageof 17
Mutagenesis|June 10, 2011
Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studiesBangshun He, Ying Zhang, Yuqin Pan, et al.Oncology Reports|December 4, 2009
The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cellsAihua Yuan, Zongfang Li, Xinqiu Li, et al.Journal of Cancer|April 21, 2018
MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal CancerXiangxiang Liu, Bangshun He, Tao Xu, et al.Molecular Medicine (Cambridge, Mass.)|June 13, 2026
The role of Dymeclin in chronic unpredictable mild stress-induced depression: maintaining the Golgi apparatus structure and regulating NLRP3 inflammasome activationLongfei Du, Zifan Ding, Lei Sun, et al.Cancer Cell International|February 8, 2018
Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expressionTianyi Gao, Xiangxiang Liu, Bangshun He, et al.Hepato-Gastroenterology|November 19, 2011
Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer riskZongdan Jiang, Zhenyu Zhang, Zhibing Wang, et al.Oncology Reports|November 4, 2009
Distinct effect of Chrysanthemum indicum Linné extracts on isoproterenol-induced growth of human hepatocellular carcinoma cellsAihua Yuan, Zongfang Li, Xinqiu Li, et al.Pharmacogenomics and Personalized Medicine|November 6, 2020
Susceptibility of PON1/PON2 Genetic Variations to Ischemic Stroke Risk in a Chinese Han PopulationYuqin Pan, Bangshun He, Huiling Sun, et al.Cancer Management and Research|May 8, 2018
Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancerXiangxiang Liu, Tao Xu, Xiuxiu Hu, et al.Aging|June 22, 2023
lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression levelZhenlin Nie, Mu Xu, Linpeng Zhou, et al.Pageof 17